Brain natriuretic peptide and heart failure, from bench to bedside;Brain Natriuretic Peptide et insuffisance cardiaque, de la recherche à la pratique clinique

Annales de Cardiologie et d'Angeiologie

Volumn 53, Issue 4, 2004, Pages 193-199

  Jourdain, P ^a   Funck, F ^a   Bellorini, M ^a  

^a CENTRE HOSPITALIER RENÉ DUBOS   (France)

Author keywords

BNP; Heart failure; Insuffisance cardiaque; Neurohormones

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

ARTICLE; DIAGNOSTIC ACCURACY; HEART FAILURE; HEART MUSCLE CELL; HUMAN; MEDICAL LITERATURE; PRACTICE GUIDELINE;

ACUTE DISEASE; BLOOD CHEMICAL ANALYSIS; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS;

EID: 2942707795     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ancard.2004.02.015     Document Type: Article

References (56)

1. Henry J., Pearce J. The possible role of cardiac stretch receptors in the induction of changes in urine flow. J. Physiol. 131:1956;572-594
2. Kangawa K., Matsuo H. Purification and complete amino acid sequence of alpha human atrial natriuretic peptide. Biochem Biophys res commun. 118:1984;131-139
3. Sudoh T., Minamino N., Kangawa K. A new natriuretic peptide in human brain nature. 332:1988;78-81
4. Kambayashi Y., Nakao K., Mukoyama M. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS lett. 259:1990;341-345
5. Ogawa Y., Nakao K., Mukoyama M. Rat brain natriuretic peptide tissue distribution and molecular form. Endocrinology. 126:1990;2225-2227
6. Hosoda K., Nakao K., Mukoyama M. Expression of brain natriuretic peptide gene in human heart. Hypertension. 17:1991;1152-1156
7. Yasue H., Yoshimura M., Sumida H. Localization and mechanism of secretion of B type natriuretic peptide in comparison with those of A type natriuretic peptide in normal subjects and patients with heart failure. Circ. 90:1994;195-203
8. Mukoyama M., Nakao K., Hosoda K. Brain Natriuretic peptide as a novel Hormone in humans. J. Clin. Invest. 87:1991;1402-1412
9. Bloch K., Seidmann J., Naftilan J. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue specific secretory pathways. Cell. 47:1986;695-702
10. Ogawa Y., Nakao K., Mukoyama M. Natriuretic peptide as cardiac hormones in normotensive and spontaneoulsy hypertensive rats. Circ Res. 69:1991;491-500
11. Hama N., Itoh H., Shirakami G. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circ. 92:1995;1558-1564
12. Chinkers M., Garbers D. The protein kinase domain of the ANP receptor is required for signalling. Science. 245:1989;1392-1394
13. Almeida F., Suzuki M., Scarbourough R. Clearance function of type C receptors of atrial natriuretic peptide in rats. Am J. Physiol. 256:1989;469-475
14. Soleihac J., Lucas E., Beaumont A. A 94 k-Da protein identify as neutral endopeptidase 24-11 can inactivate atrial natriuretic peptide in the vascular endothelium. Mol Pharmacol. 41:1992;609-614
15. Groenning B.A., Nilsson J.C., Sondergaard L., Kjaer A., Larsson H.B., Hildebrandt P.R. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail. 3:2001;699-708
16. Vogeser M., Jacob K. B-type natriuretic peptide (BNP) validation of an immediate response assay. Clin Lab. 47:2001;29-33
17. Hughes D., Talwar S., Squire I.B., Davies J.E., Ng L.L. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Clin Sci. 96:1999;373-380
18. Cataliotti A., Malatino L.S., Jougasaki M. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc. 76:2001;1111-1119
19. Logeart D., Sadubry C., Beyne P., et al. Comparative value of Doppler echocardiography and BNP in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol. 40:2002;1794-1800
20. Mc Donagh T., Robb S., Murdoch D. Biochemical detection of left ventricular systolic dysfunction. Lancet. 351:1998;9-13
21. Lerman A., Gibbons R., Rodeheffer R. Circulating N terminal atrial Natriuretic peptide as a marker for symptomless left ventricular dysfunction. Lancet. 341:1993;1105-1109
22. Omland T., Aakvaag A., Vik H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairement. Heart. 76:1996;232-237
23. Choy A., Darbar D., Lang C. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical echocardiographic and neurohormonal methods. Br heart J. 72:1994;16-22
24. Sumida H., Yasue H., Yoshimura M. Comparison of secretion pattern between A type and B type Natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol. 25:1995;1105-1110
25. Nagaya N., Nishikimi T., Goto Y. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J. 135:1998;21-28
26. Suzuki T., Hayashi D., Yamazaki T. Elevated B type natriuretic peptide levels after anthracyclines administration. Am H J. 136:1998;362-363
27. Kitaoka H., Takara J., Hitomi N. Natriuretic peptides and contractile reserve in dilated cardiomyopathy. Lancet. 352:1998;487
28. Takemura G., Takatsu Y., Doyama K. Expression of atrial and brain Natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol. 31:1998;254-265
29. Hetmanski D.J., Sparrow N.J., Curtis S. Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community. Heart. 84:2000;440-441
30. Luchner A., Burnett J.C. Jr, Jougasaki M., et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertension. 18:2000;1121-1128
31. Cowie M., Struthers A., Wood D. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1347-1351
32. Maisel A.S., Krishnaswamy P., Nowak R.M. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:2002;161-167
33. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 106:2002;416-422
34. Jourdain P., Funck F., Bellorini M., et al. Apports du peptide natriuretique de type B dans la prise en charge aux urgences des patients suspects d'insuffisance cardiaque. Arch Mal Coeur Vaiss. 95:2002;763-767
35. Davis M., Espiner E., Richards G. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 343:1994;440-444
36. Maisel A. Algorithm for using b-type natriuretic peptide levels in the diagnosis and management of congestive heart failure. Critical Pathways in Cardiology. I:(2):2000;68-73
37. Wright S.P., Doughty R.N., Gamble G.D., et al. N-terminal BNP in the community diagnosis of suspected heart failure: what is an appropriate diagnostic threshold? Eur Heart J. 23:(Suppl 4):2002;271
38. Maeda K., Tsutamoto T., Wada A. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am H J. 135:1998;825-832
39. Kruger S., Graf J., Kunz D. brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 40:2002;718-722
40. Jourdain P., Funck F., Bellorini M. bedside B type natriuretic peptide and functional capacity in chronic heart failure. Eur Heart failure J. 5:2003;155-160
41. Koglin J., Pehlivanli S., Schwaiblmair. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 38:2001;1934-1941
42. Tsutamoto T., Wada A., Maeda K. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516
43. Cheng V., Kazanagra R., Garcia A. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 37:2001;386-391
44. Hulsmann M., Berger R., Sturm B. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J. 23:2002;886-891
45. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 105:2002;2392-2397
46. Wei C., Heublein D., Perrella M. Natriuretic peptide system in human heart failure. Circ. 88:1993;1004-1009
47. Tsutamoto T., Wada A., Maeda K. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Circ. 96:1997;509-516
48. Lee S.C., Stevens T.L., Sandberg S.M., Heublein D.M. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail. 8:2002;149-154
49. Richards A., Doughty R., Nicholls M. Neurohumoral prediction of benefit from Carvedilol in ischaemic left ventricular dysfunction. Circ. 99:1999;786-792
50. Levett J., Marinelli C., Lund D. Effects of β blockade on neurohormonal responses to neurochemichal markers in pacing induced heart failure. Am J. Physiol. 266:1994;468-475
51. Motwani J.G., Mc Alpine H., Kennedy N. Plasma BNP as an indicator for ACE inhibition after myocardial infarction. Lancet. 341:1993;1109-1113
52. Veldhuisen D.J., Genth Zotz S., Brouwer J. High vs low dose ACE inhibition in chronic heart failure. J Am Coll Cardiol. 32:1998;1811-1818
53. Troughton R., Frampton C., Yandle T. Treatment of heart failure guided by plasma amino terminal natriuretic peptide concentrations. Lancet. 355:2000;1126-1130
54. Yu C.M., Sanderson J.E. Plasma brain natriuretic peptide: an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail. 1:1999;59-65
55. Kazanegra R., Cheng V., Garcia A. A rapid test for BNP correlates with falling wedge pressure in patients treated for decompensated heart failure et al. J of Cardiac failure. 7:2001;21-29
56. Cowie M., Jourdain P., Maisel A., et al. Clinical applications of BNP testing. Review article Eur H J. 24:2003;1710-1718